Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 28, 2016Cannabis and Cannabinoid ResearchOpen Access

Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes

View Full Paper
Ask AI
Bookmark
Share

Authors

EREthan B. RussoVashon Partners (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ethan B. Russo (2016) studied this question.

synapsesocial.com/papers/69dd237f4006ebb8efe531a9https://doi.org/10.1089/can.2016.0009
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Endocannabinoids control spasticity in a multiple sclerosis model2000 · 381 citations
  2. 2Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications1999 · 176 citations
  3. 3Structural requirements for 5-HT 2A and 5-HT 1A serotonin receptor potentiation by the biologically active lipid oleamide1998 · 95 citations
  4. 4Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of Sativex®, a Cannabis‐Based Medicine2007 · 230 citations
  5. 5Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life2011 · 134 citations